Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

iMap 3D Mapping & Navigation System (iMap System)

K-Number: K201094 · 2021-08-16

Decision Date2021-08-16
Product CodeDQK
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

iMap 3D Mapping & Navigation System (iMap System) is a medical device manufactured by Cardionxt, Inc.. It received FDA 510(k) clearance on 2021-08-16 under approval number K201094. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the iMap 3D Mapping & Navigation System (iMap System)?

iMap 3D Mapping & Navigation System (iMap System) is a medical device that received FDA 510(k) clearance on 2021-08-16. It is manufactured by Cardionxt, Inc.. The 510(k) number is K201094.

When was iMap 3D Mapping & Navigation System (iMap System) approved by the FDA?

iMap 3D Mapping & Navigation System (iMap System) received FDA 510(k) clearance on 2021-08-16, under approval number K201094.

What company makes iMap 3D Mapping & Navigation System (iMap System)?

iMap 3D Mapping & Navigation System (iMap System) is manufactured by Cardionxt, Inc..

What is the FDA product code for iMap 3D Mapping & Navigation System (iMap System)?

The FDA product code for iMap 3D Mapping & Navigation System (iMap System) is DQK.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: DQK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.